A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 29, 2024

Primary Completion Date

October 29, 2024

Study Completion Date

October 29, 2024

Conditions

Healthy

Interventions

BIOLOGICAL

Cohort A

Administered IV High dose

BIOLOGICAL

Cohort B

Administered SC Low Dose

BIOLOGICAL

Cohort C

Administered SC Mid Dose

BIOLOGICAL

Cohort D

Administered SC High Dose

Trial Locations (1)

Research Site, Cincinnati

All Listed Sponsors

lead

Uniquity One (UNI)

INDUSTRY

NCT06640920 - A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants | Biotech Hunter | Biotech Hunter